Show simple item record

dc.contributor.authorNewman, LP
dc.contributor.authorNjoroge, A
dc.contributor.authorBen-Youssef, L
dc.contributor.authorMerkel, M
dc.contributor.authorGatuguta, A
dc.contributor.authorTon, Q
dc.contributor.authorObimbo, EM
dc.contributor.authorWamalwa, D
dc.contributor.authorLohman-Payne, B
dc.contributor.authorRichardson, BA
dc.contributor.authorNduati, R
dc.contributor.authorFarquhar, C
dc.identifier.citationPediatr Infect Dis J. 2014 Mar 10en_US
dc.description.abstractThis paper describes results from a cross-sectional study among HIV-infected children 15 months to 12 years of age who were receiving antiretroviral therapy. We found a low prevalence of measles IgG seropositivity (45.7%) and identified CD4% ≥ 25 as a predictor. Most HIV-infected children on ART were not measles seropositive and might benefit from revaccination.en_US
dc.publisherUniversity of Nairobien_US
dc.titleMeasles Seropositivity in HIV-Infected Kenyan Children on Antiretroviral Therapy.en_US
dc.typeWorking Paperen_US

Files in this item


There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record